Patient Prioritization of Items to Develop the Patient-Reported Impact of Dermatological Diseases Measure: A Global Delphi Study

    February 2024 in “ Journal of the European Academy of Dermatology and Venereology ”
    Nirohshah Trialonis‐Suthakharan, Rachael Pattinson, Nasim Tahmasebi Gandomkari, Jennifer Austin, Christine Janus, Nicholas Courtier, Rachael M. Hewitt, Christine Bundy, Matthias Augustin
    Image of study
    TLDR The study created a 27-item measure to assess the impact of skin diseases.
    This study developed the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure through a global Delphi process, involving 1154 participants in Round 1 and 493 in Round 2, from 65 countries. The study identified 27 prioritized items across five domains: physical, daily life, psychological, social, and financial impacts, to form the first draft of PRIDD. Key impacts included concerns about nails, skin, and hair, physical discomfort, and psychological stress. The study emphasized the need for a dermatology-specific patient-reported outcome measure (PROM) that captures impacts not addressed by existing PROMs, such as feelings of abandonment and role performance issues. The results advocate for integrating psychological support into dermatological care and highlight the importance of a biopsychosocial approach in treatment. The draft is ready for pilot testing to assess its comprehensiveness and relevance.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 35 results

      community FINASTRIDE and switch to DUTASTRIDE, my experience

      in Progress Pictures  135 upvotes 2 months ago
      The user shared their experience with Finasteride and Dutasteride for hair loss. They initially had success with Finasteride but switched to Dutasteride after experiencing shedding, which continued, and are now considering a hair transplant.

      community One+ year 1mg Fin, Ketoconazole, and 3.75 Oral Min. I have DUPA. Switched from Topical to Oral Min.

      in Progress Pictures  142 upvotes 2 years ago
      A user's experience with hair loss treatments such as finasteride, ketoconazole, and oral minoxidil that have not yielded any results; other users suggest shaving the head or getting a wig, while others offer additional advice such as seeing a dermatologist, checking thyroid levels, switching to dutasteride and adding needling, and trying stemoxydine.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community 9 Month Status Update. I am so glad I started when I did

      in Progress Pictures  1208 upvotes 7 months ago
      A user shared a 9-month update on hair loss treatment, reporting positive results from taking 1 mg of finasteride and 1.25 mg of minoxidil daily. The discussion includes varied experiences with these treatments, questions about side effects, and comments on the unpredictability of treatment effectiveness.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

    Similar Research

    5 / 1000+ results